In Ongoing Suit, Alnylam Claims Partner Tekmira Misappropriated Trade Secrets
June 30, 2011
In Ongoing Suit, Alnylam Claims Partner Tekmira Misappropriated Trade Secrets
Alnylam charged Tekmira with wrongly using trade secrets to bolster its own drug delivery technology-development efforts and to file a patent application on Alnylam's phase I liver cancer drug.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Tekmira Alleges Theft of Confidential Documents by AlCana
November 17, 2011 / Gene Silencing News - Alnylam Claims Legal Right to Sue Tekmira Over Licensed Patents
March 22, 2012 / Gene Silencing News - Alnylam to Cut a Third of Its Staff on Heels of Pipeline Reorganization
January 26, 2012 / Gene Silencing News - AlCana Denies Breaking Non-Compete Pact as Tekmira Decries Deception in Ongoing Lawsuit
August 18, 2011 / Gene Silencing News - Tekmira Amends Alnylam Lawsuit to Include AlCana Technologies
June 9, 2011 / Gene Silencing News